Boehringer Ingelheim eliminates 725 positions; 50 in state
RIDGEFIELD – Boehringer Ingelheim announced Wednesday that it has eliminated 725 positions in the U.S. including 50 in Connecticut, as the German pharmaceutical company continues an organizational restructuring.
Erin Crew, a company spokeswoman, said most of the 50 jobs lost in Connecticut will come from its headquarters in Ridgefield. The remaining 675 jobs, most in sales, come from various other company locations throughout the U.S.
Following a careful examination of our human pharmaceuticals business, we made the difficult decision to eliminate (the positions), Crew said in a statement. Many of the people impacted will continue to have the opportunity to pursue new roles within the Company.
The actions we are taking now will help us reinvent the way we serve the needs of our patients, and enable us to continue to make significant investments in Research and Development to continue to identify new medical breakthroughs.
We are sympathetic to the impact this decision may have on Boehringer Ingelheim employees and their families, she added. We are committed to treating all employees with dignity, respect and sensitivity. We will support affected employees in a number of ways, including severance, outplacement services, and identifying other employment opportunities within the Boehringer Ingelheim network, as appropriate.
Boehringer Ingelheim employs about 2,700 people in Connecticut and 47,000 globally. Its 300-acre campus spans Ridgefield and Danbury.
Ridgefield First Selectman Rudy Marconi expressed sympathy for the employees who lost their jobs.
Any time someone loses a job it s a concern to all of us, Marconi said. Mostly it s a concern for Boehringer Ingelheim, but they are restructuring their objectives and that requires that they move people around. I know that if they are BI employees, they are the best, and they should be successful in securing employment.
Marconi said he is eager to help if any of the affected employees are Ridgefield residents.
My door is open, or give me a call, he said. I m here to help in any way I can.
Boehringer Ingelheim eliminated 900 positions in 2014 and trimmed the local workforce by about two percent in February 2015.
The company announced in April at its Annual Conference in Ingelheim am Rhein in Germany that 2015 was a solid year for the research-driven firm and that each business area generated growth. In its 2016 outlook, the company predicted minor sales growth compared to 2015.